What is Vivanza Biosciences Ltd (530057) share price return in the past 10 years?

Vivanza Biosciences Ltd share price has declined -11.8% annually (CAGR) over the past ten years.

What is the share price of Vivanza Biosciences Ltd (530057)?

Company share prices are keep on changing according to the market conditions. The current trading price of Vivanza Biosciences Ltd (530057) on 15-Apr-2026 16:59:59 at 16:59 is 2.00.

What is the P/E ratio of Vivanza Biosciences?

The latest standalone P/E ratio of Vivanza Biosciences as of 15-Apr-2026 is 0.00.

What is the P/B ratio of Vivanza Biosciences Ltd (530057)?

The latest standalone P/B ratio of Vivanza Biosciences Ltd (530057) as of 15-Apr-2026 is 1.75.

What is the 52-week high and low of Vivanza Biosciences Ltd (530057)?

The 52-week high of Vivanza Biosciences Ltd (530057) is Rs. 2.94 and the 52-week low is Rs. 1.75.

Vivanza Biosciences Ltd (530057) Share Analysis – Quality, Valuation Zone & Price Trend & DeciZen Rating

Name: Vivanza Biosciences Ltd (530057)
Brand: Vivanza Biosciences

Vivanza Biosciences Ltd (530057) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Key Metrics

Market Cap

₹8 Cr.

P/E Ratio

0.00

Price to Book (P/B)

1.75

Price to Sales (P/S)

0.08

EV/EBITDA

-827.11

Return on Capital Employed (ROCE)

-3.76%

Current Price

₹2

Return on Equity (ROE)

-15.91%

Return on Assets (ROA)

-4.52%

Operating Profit Margin

-11.9%

Net Profit Margin

-23.62%

Gross Profit Margin

-23.1%

Book Value per Share

₹1.2

Sales Growth (YoY)

-79.6%

Sales Growth (3 Years)

-31.51%

Operating Profit Growth (1 Year)

-144.44%

Operating Profit Growth (3 Years)

NAN%

Net Profit Growth (1 Year)

-318.75%

52-Week Low / High

₹2 / 3

Net Profit Growth (3 Years)

NAN%

Dividend Yield

0.00%

Promoter Holding

20.02%

Pledged shares (%)
of Promoter's holding (%)

0.00%

Check Before You Invest

Q.1 Revenue growth of Vivanza Biosciences Ltd?

Vivanza Biosciences Ltd revenue growth is -79.6% for FY-2025 , which is below its 5 year CAGR of -20.7% , indicating slower growth.

Q.1 Promoter shareholding and pledge status of Vivanza Biosciences Ltd?

Promoters hold 20.02% of the Vivanza Biosciences Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Revenue growth of Vivanza Biosciences Ltd vs industry peers?

Vivanza Biosciences Ltd revenue CAGR is -20.69% , compared to the industry median CAGR of 0% , indicating slower growth and losing its market share.

Q.1 Which industry/sub-sector does Vivanza Biosciences Ltd belong to?

Vivanza Biosciences Ltd belongs to the Miscellaneous sector, operating specifically within the Trading segment.

Q.1 Stock return of Vivanza Biosciences Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of -11.6% based on the current price.

DeciZen - make an informed investing decision on Vivanza Biosciences

Based on:

Data

M-Cap below 100cr DeciZen not available

Vivanza Biosciences stock performance

Key Ratios

Is Vivanza Biosciences Ltd an attractive stock to invest in?

1. Is Vivanza Biosciences Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Vivanza Biosciences Ltd is a below average quality company.

2. Is Vivanza Biosciences Ltd undervalued or overvalued?

The key valuation ratios of Vivanza Biosciences Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

3. Is Vivanza Biosciences Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Vivanza Biosciences Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray :

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	-10.6%	-4.9%	14.3%	-0.6%	6.1%	17.8%	15.2%	11.7%	9%	-3.8%	-
Value Creation Index ⓘ	-1.8	-1.4	0.0	-1.1	-0.6	0.3	0.1	-0.2	-0.4	-1.3	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	0	3.5	6.4	2.2	9.4	9.2	9.2	14.2	14.4	2.9	107
Sales YoY Gr.	-	NA	85.6%	-65.5%	322.1%	-1.6%	-0.8%	55.3%	1.4%	-79.6%	-
Adj EPS ⓘ	-0.3	-0	0.1	-0.1	-0.1	0	0.1	0.2	0.1	-0.2	-0.1
YoY Gr.	-	NA	NA	-283.3%	NA	NA	366.7%	7.1%	-46.7%	-312.5%	-
BVPS (₹) ⓘ	0.1	0.9	1	0.9	0.8	0.8	1	1.1	1.2	1	1.2
Adj Net Profit ⓘ	-0.1	-0.2	0.2	-0.5	-0.2	0.1	0.5	0.6	0.3	-0.7	-0
Cash Flow from Ops. ⓘ	-0.1	-2	-0.2	1.4	2.8	-3.1	-0.7	0.2	1.8	-2.5	-
Debt/CF from Ops. ⓘ	-10.9	-0.3	-4.7	0.7	0.1	-0.1	-6.5	40.8	1.8	-2.5	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	-20.7%	-31.5%	-79.6%
Adj EPS ⓘ	NA	NA	-206.7%	-312.5%
BVPSⓘ	25.6%	4.3%	1.7%	-14.4%
Share Price	-11.8%	-30.1%	-51.8%	-11.1%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	-63.2	-9.3	6.3	-12.2	-6.1	3	15	14.3	7	-15.8	-7.3
Op. Profit Mgn % ⓘ	0	-4.6	9.9	-1.3	-3.2	1.4	2	5.4	5.6	-11.9	-0.1
Net Profit Mgn % ⓘ	0	-5	3.7	-20.2	-2.2	1.1	5.9	4.1	2.2	-23.4	-0.3
Debt to Equity ⓘ	20.3	0.1	0.2	0.3	0.1	0.1	1.2	1.5	0.7	1.5	-
Working Cap Days ⓘ	0	418	513	1,865	486	441	427	394	421	1,660	1,524
Cash Conv. Cycle ⓘ	0	137	114	96	-16	13	160	96	103	675	301

Recent Performance Summary

Sales growth is good in last 4 quarters at 2684.62%

Return on Equity is Poor

Sales growth has been subdued in last 3 years -31.51%

Debt to equity has increased versus last 3 years average to 1.52

Latest Financials

	Standalone	Consolidated
TTM EPS (₹)	-0.1	-0
TTM Sales (₹ Cr.)	107	110
BVPS (₹) ⓘ	1.2	1.2
Reserves (₹ Cr.) ⓘ	1	1
P/BV ⓘ	1.75	1.70
PE ⓘ	0.00	0.00

From the Market
52 Week Low / High (₹)	1.75 / 2.94
All Time Low / High (₹)	0.05 / 21.00
Market Cap (₹ Cr.)	8.2
Equity (₹ Cr.)	4
Face Value (₹)	1
Industry PE ⓘ	24.4

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Vivanza Biosciences - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	0	3.47	6.44	2.22	9.37	9.22	9.15	14.21	14.41	2.94
Operating Expenses ⓘ +	0.06	3.64	5.80	2.25	9.66	9.09	9.07	13.47	13.61	3.30
Manufacturing Costs	0	0.02	0.09	0	0.04	0.01	0.10	0	0.03	0.01
Material Costs	0	3.07	5.53	1.98	9.14	8.56	8.48	12.96	12.98	2.62
Employee Cost	0	0.26	0.06	0.02	0.10	0.11	0.08	0.22	0.31	0.36
Other Costs ⓘ	0.06	0.28	0.13	0.25	0.39	0.41	0.41	0.29	0.28	0.31
Operating Profit ⓘ	-0.06	-0.16	0.64	-0.03	-0.30	0.13	0.07	0.74	0.81	-0.36
Operating Profit Margin (%)	-	-4.6%	9.9%	-1.3%	-3.2%	1.4%	0.8%	5.2%	5.6%	-12.3%
Other Income ⓘ +	0	0.05	0	0	0.53	0.50	0.83	0.39	0.05	0.03
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	0	0.04	0.37	0.42	0.44	0.47	0.43	0.43	0.42	0.35
Depreciation ⓘ	0	0	0	0	0	0.01	0.01	0	0.01	0.01
Profit Before Tax ⓘ	-0.06	-0.16	0.27	-0.45	-0.20	0.15	0.46	0.69	0.43	-0.69
Tax ⓘ	0	0	0.03	0	0	0.05	0	0.12	0.11	0
Profit After Tax	-0.06	-0.16	0.24	-0.45	-0.20	0.10	0.46	0.57	0.32	-0.70
PAT Margin (%)	-	-4.6%	3.7%	-20.2%	-2.2%	1.1%	5.1%	4.0%	2.2%	-23.6%
Adjusted EPS (₹)	-0.3	-0.0	0.1	-0.1	-0.1	0.0	0.1	0.1	0.1	-0.2
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	0.02	3.68	3.92	3.47	3.27	3.37	3.83	4.40	4.72	4.02
Share Capital ⓘ	0.19	4	4	4	4	4	4	4	4	4
Reserves ⓘ	-0.16	-0.32	-0.08	-0.53	-0.73	-0.63	-0.17	0.40	0.72	0.02
Debt +	0.50	0.53	0.77	0.90	0.18	0.18	4.42	6.56	3.26	6.09
Long Term Debt	0	0	0	0	0	0	0	0	0.78	0.78
Short Term Debt	0.50	0.53	0.77	0.90	0.18	0.18	4.42	6.56	2.49	5.32
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	0.05	2.56	4.84	5.75	8.14	3.86	5.48	8.66	8.23	3.22
Others Liabilities ⓘ	0.06	0.16	0.14	0.71	0.69	0.53	0.47	0.82	0.66	0.58
Total Liabilities ⓘ	0.64	6.93	9.66	10.83	12.28	7.93	14.21	20.44	16.87	13.91
Fixed Assets
Net Fixed Assets ⓘ +	0	0	0	0	0	0.01	0	0	0.03	0.02
Gross Block	0	0	0	0	0	0.02	0.02	0.02	0.06	0.07
Accumulated Depreciation	0	0	0	0	0	0.01	0.02	0.02	0.03	0.05
CWIP ⓘ	0	0	0	0	0	0	0	0	0	0
Investments ⓘ	0	1.91	1.91	1.91	1.91	1.91	1.91	1.91	1.91	1.91
Inventories	0	1.81	2.28	1.91	0.85	0.40	2.23	1.61	1.80	1.84
Trade Receivables	0	2.53	5.07	5.54	6.41	6.11	7.35	12.18	10.37	7.39
Cash Equivalents	0.03	-2.33	-3.02	-3.03	-2.81	-3.11	0.02	0.10	0.09	0.05
Others Assets ⓘ	0.60	3.01	3.41	4.50	5.92	2.61	2.69	4.62	2.67	2.70
Total Assets ⓘ	0.64	6.93	9.66	10.83	12.28	7.93	14.21	20.44	16.87	13.91

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	-0.05	-1.98	-0.16	1.37	2.80	-3.08	-0.68	0.16	1.80	-2.47
PBT ⓘ	-0.06	-0.16	0.27	-0.45	-0.20	0.15	0.46	0.69	0.43	-0.69
Adjustment ⓘ	0	0.07	0.36	0.43	0.44	0.48	0.41	0.42	0.43	0.36
Changes in Working Capital ⓘ	0.01	-1.9	-0.79	1.39	2.56	-3.65	-1.55	-0.83	1.05	-2.14
Tax Paid ⓘ	0	0	0	0	0	-0.05	-0	-0.12	-0.11	0
Cash Flow From Investing Activity ⓘ +	0	1.90	0	0	0	-0.02	0	0	-0.04	-0.01
Capex	0	0	0	0	0	-0.02	0	0	-0.04	-0.01
Net Investments	0	1.90	0	0	0	0	0	0	0	0
Others ⓘ	0	0	0	0	0	0	0	0	0	0
Cash Flow From Financing Activity ⓘ +	0.02	-2.28	-0.53	-1.38	-2.58	2.80	0.65	-0.08	-1.77	2.44
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0	0	0	0
Interest Paid ⓘ	0	-0.04	-0.36	-0.42	-0.44	-0.47	-0.41	-0.42	-0.41	-0.35
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0.02	-2.24	-0.17	-0.96	-2.14	3.27	1.06	0.34	-1.36	2.79
Net Cash Flow ⓘ	-0.02	-2.36	-0.69	-0.01	0.22	-0.30	-0.03	0.09	-0.01	-0.04

Finance Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	-79.68	-8.58	6.32	-12.16	-6.05	3.01	12.89	13.84	6.97	-15.91
ROCE (%)	-10.61	-4.88	14.33	-0.63	6.07	17.83	15.19	11.66	8.96	-3.76
Asset Turnover Ratio	0	0.92	0.78	0.22	0.82	0.91	0.83	0.82	0.77	0.19
PAT to CFO Conversion(x)	N/A	N/A	-0.67	N/A	N/A	-30.8	-1.48	0.28	5.63	N/A
Working Capital Days
Receivable Days	0	266	215	872	231	248	269	251	286	1,101
Inventory Days	0	190	116	344	54	25	52	49	43	226
Payable Days	0	155	244	973	277	256	201	199	237	796

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Vivanza Biosciences Ltd FAQs

The current trading price of Vivanza Biosciences on 15-Apr-2026 16:59 is ₹2.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 14-Apr-2026 the market cap of Vivanza Biosciences stood at ₹8.16 Cr

The latest P/E ratio of Vivanza Biosciences as of 14-Apr-2026 is 0.00.

The latest P/B ratio of Vivanza Biosciences as of 14-Apr-2026 is 1.75.

The 52-week high of Vivanza Biosciences is ₹2.94 and the 52-week low is ₹1.75.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Vivanza Biosciences is ₹107 ( Cr.) .

About Vivanza Biosciences Ltd

Head quartered in Gujarat, Vivanza Biosciences Limited came into existence in April 2016 with the sole aim to further spread its wings in global market with global quality pharmaceutical products at competitive pricing system. It is the bridge between people, Medical Practitioners and the Patients and together it is a healthcare organization dedicated to improving the lives of people globally.

Business area of the company

The company is engaged in the business of business of Pharmaceutical Products.

Products

Gloves
Surgicals

You have 1 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Vivanza Biosciences Ltd (530057) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Vivanza Biosciences Share Price